Covered recipient · General Payments record
TUDOR C JIANU
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2023
$11,172.06
- Reported across 724 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $345.66 | 16 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $167.34 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $47.25 | 2 |
| Lilly USA, LLC | $22.56 | 1 |
| Organon LLC | $20.71 | 1 |
| Amgen Inc. | $20.51 | 1 |
| Mallinckrodt Hospital Products Inc. | $19.77 | 1 |
| ANI Pharmaceuticals, Inc. | $19.71 | 1 |
| GlaxoSmithKline, LLC. | $14.85 | 1 |
| Kyowa Kirin, Inc. | $12.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.51 | 08/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997566605 | CMS |
| ABBVIE INC. | $28.65 | 08/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997566607 | CMS |
| ABBVIE INC. | $20.89 | 08/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997566609 | CMS |
| ABBVIE INC. | $26.97 | 09/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997566611 | CMS |
| ABBVIE INC. | $20.89 | 09/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997566613 | CMS |
| ABBVIE INC. | $18.28 | 09/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997566615 | CMS |
| ABBVIE INC. | $28.15 | 10/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997566617 | CMS |
| Amgen Inc. | $20.51 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020180619 | CMS |
| ANI Pharmaceuticals, Inc. | $19.71 | 09/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034117967 | CMS |
| GlaxoSmithKline, LLC. | $14.85 | 10/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000869961 | CMS |
| Kyowa Kirin, Inc. | $12.96 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1027027743 | CMS |
| Lilly USA, LLC | $22.56 | 09/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032373987 | CMS |
| Mallinckrodt Hospital Products Inc. | $19.77 | 09/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1042844195 | CMS |
| Novartis Pharmaceuticals Corporation | $22.60 | 08/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992334481 | CMS |
| Novartis Pharmaceuticals Corporation | $24.65 | 08/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992334485 | CMS |
| Organon LLC | $20.71 | 09/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1047008751 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.